Table 1 Clinical parameters of patients

From: Spatial transcriptomics reveals strong association between SFRP4 and extracellular matrix remodeling in prostate cancer

 

Relapse

 
 

Yes (n = 27)

No (n = 10)

Clinical GG post-surgery

  

 2

7

8

 3

10

2

 4

4

0

 5

6

0

Age at radical prostatectomy

 50–59

10

6

 60–69

14

4

 70–73

3

0

Preoperative PSA

 4.0–9.9

11

4

 10.0–19.9

9

5

 ≥20.0

7

1

Clinical T-stagea

 T2c

9

9

 T3a

6

0

 T3b

12

0

Months from surgery to relapse

 ≤ 12

15

 

 ≤ 48

10

 

 > 48

2

 

Omics analysis

 Spatial transcriptomics

5

3

 Bulk transcriptomics

27

10

 Bulk methylomics

10

6

 Masson’s trichrome stain

5

3

 LMD proteomics

5

3

  1. Includes clinically recorded grade group (GG), T-stage after surgery, age at surgery, serum PSA before surgery and the number of months from surgery to relapse (for the patients with relapse). An overview of the number of patients with measurements for the different omics analysis is also presented.
  2. aOne relapse-free patient had unknown T-stage.
Back to article page